Cerus (CERS) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cerus | 549.42 Mn | 469.73 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.29% |
| Dec 31, 2025 | -1.78% |
| Sep 30, 2025 | -5.65% |
| Jun 30, 2025 | -9.89% |
| Mar 31, 2025 | -11.23% |
| Dec 31, 2024 | -12.73% |
| Sep 30, 2024 | -12.52% |
| Jun 30, 2024 | -15.79% |
| Mar 31, 2024 | -18.49% |
| Dec 31, 2023 | -19.85% |
| Sep 30, 2023 | -23.44% |
| Jun 30, 2023 | -23.29% |
| Mar 31, 2023 | -19.08% |
| Dec 31, 2022 | 6.32% |
| Sep 30, 2022 | 6.80% |
| Jun 30, 2022 | 5.36% |
| Mar 31, 2022 | 4.98% |
| Dec 31, 2021 | 0.43% |
| Sep 30, 2021 | -4.06% |
| Jun 30, 2021 | -2.34% |
| Mar 31, 2021 | 2.67% |
| Dec 31, 2020 | 38.66% |
| Sep 30, 2020 | 43.22% |
| Jun 30, 2020 | 42.85% |
| Mar 31, 2020 | 39.41% |
| Dec 31, 2019 | -0.43% |
| Sep 30, 2019 | -5.61% |
| Jun 30, 2019 | -4.20% |
| Mar 31, 2019 | -5.95% |
| Dec 31, 2018 | -3.74% |
| Sep 30, 2018 | -1.32% |
| Jun 30, 2018 | -6.47% |
| Mar 31, 2018 | -8.00% |
| Dec 31, 2017 | -2.12% |
| Sep 30, 2017 | -7.69% |
| Jun 30, 2017 | -3.85% |
| Mar 31, 2017 | -2.58% |
| Dec 31, 2016 | 10.53% |
| Sep 30, 2016 | 26.59% |
| Jun 30, 2016 | 10.75% |
| Mar 31, 2016 | 11.18% |
| Dec 31, 2015 | 70.54% |
| Sep 30, 2015 | 78.07% |
| Jun 30, 2015 | 81.39% |
| Mar 31, 2015 | 78.57% |
| Dec 31, 2014 | 31.37% |
| Sep 30, 2014 | 43.00% |
| Jun 30, 2014 | 49.45% |
| Dec 31, 2013 | 21.72% |